Context Therapeutics Inc. (CNTX) SEC Filings — 2025
14 SEC filings for Context Therapeutics Inc. (CNTX) in 2025.
Filings
- Context Therapeutics Narrows Q3 Loss, R&D Spend Declines — 10-Q · Nov 5, 2025
- Context Therapeutics Files 8-K — 8-K · Oct 24, 2025
- Context Therapeutics Files 8-K Under 'Other Events' — 8-K · Oct 20, 2025
- Context Therapeutics Faces Delisting Notice — 8-K · Sep 2, 2025
- Context Therapeutics Narrows Q2 Loss Amidst Clinical Pipeline Progress — 10-Q · Aug 6, 2025
- Context Therapeutics Inc. Files 8-K on Security Holder Vote — 8-K · Jun 12, 2025
- Context Therapeutics Inc. Files 8-K — 8-K · Jun 2, 2025
- Context Therapeutics Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Context Therapeutics Inc. Files 2025 Proxy Statement — DEF 14A · Apr 15, 2025
- Context Therapeutics Inc. Files 8-K — 8-K · Apr 9, 2025
- Context Therapeutics Inc. 10-K Filing — 10-K · Mar 20, 2025
- Context Therapeutics Faces Delisting Concerns — 8-K · Feb 28, 2025
- Context Therapeutics Inc. Files 8-K — 8-K · Jan 14, 2025
- Context Therapeutics Inc. Files 8-K: Board & Compensation Updates — 8-K · Jan 13, 2025